Breaking News Instant updates and real-time market news.

DKNG

DraftKings

$50.62 /

-2.54 (-4.78%)

08:46
06/15/21
06/15
08:46
06/15/21
08:46

Hindenburg Research takes short position in shares of DraftKings

DraftKings' stock is up nearly 400% since its deal announcement, and while the company has inked major deals with the NFL, NBA, NASCAR, PGA and UFC, DraftKings' merger with SBTech also brings exposure to extensive dealings in black-market gaming, money laundering and organized crime, Hindenburg Research said. As one former employee told the firm, DraftKings' subsidiary SBTech has "sold to plenty of mobs," which is in sharp contrast to the clean image of DraftKings' brand-conscious partners and advisors. The firm thinks DraftKings has "systematically skirted the law and taken elaborate steps to obfuscate its black market operations." Hindeburg has taken a short position in shares of DraftKings. Reference Link

  • 19

    Jun

  • 07

    Oct

DKNG DraftKings
$50.62 /

-2.54 (-4.78%)

06/02/21 Morgan Stanley
DraftKings price target lowered to $58 from $63 at Morgan Stanley
05/24/21 Argus
DraftKings price target lowered to $60 from $78 at Argus
05/12/21
Fly Intel: Top five analyst upgrades
05/12/21 Berenberg
DraftKings upgraded to Hold after 16% pullback at Berenberg

TODAY'S FREE FLY STORIES

Earnings
Arcutis Biotherapeutics reports Q2 EPS (84c), consensus (90c) » 17:00
08/05/21
08/05
17:00
08/05/21
17:00
ARQT

Arcutis Biotherapeutics

$21.74 /

+0.89 (+4.27%)

Cash, cash equivalents,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARQT Arcutis Biotherapeutics
$21.74 /

+0.89 (+4.27%)

ARQT Arcutis Biotherapeutics
$21.74 /

+0.89 (+4.27%)

06/29/21 Mizuho
Arcutis Biotherapeutics initiated with a Buy at Mizuho
05/27/21 Morgan Stanley
Arcutis Biotherapeutics initiated with an Overweight at Morgan Stanley
02/02/21 Truist
Arcutis Biotherapeutics price target raised to $48 from $38 at Truist
02/01/21 Cowen
Arcutis Biotherapeutics price target raised to $80 from $55 at Cowen
ARQT Arcutis Biotherapeutics
$21.74 /

+0.89 (+4.27%)

  • 03
    Feb
  • 02
    Oct
ARQT Arcutis Biotherapeutics
$21.74 /

+0.89 (+4.27%)

Earnings
MP Materials reports Q2 EPS 15c, consensus 13c » 17:00
08/05/21
08/05
17:00
08/05/21
17:00
MP

MP Materials

$36.10 /

+0.48 (+1.35%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MP MP Materials
$36.10 /

+0.48 (+1.35%)

MP MP Materials
$36.10 /

+0.48 (+1.35%)

07/23/21
Fly Intel: Top five analyst initiations
07/23/21 DA Davidson
MP Materials initiated with a Buy at DA Davidson
06/29/21 Baird
Baird starts MP Materials at Outperform, sees 'superior multiple' warranted
06/29/21 Baird
MP Materials initiated with an Outperform at Baird
MP MP Materials
$36.10 /

+0.48 (+1.35%)

  • 24
    Mar
MP MP Materials
$36.10 /

+0.48 (+1.35%)

MP MP Materials
$36.10 /

+0.48 (+1.35%)

MP MP Materials
$36.10 /

+0.48 (+1.35%)

Earnings
B&G Foods backs FY21 revenue view of $2.05B-$2.10B, consensus $2.16B » 17:00
08/05/21
08/05
17:00
08/05/21
17:00
BGS

B&G Foods

$28.18 /

+0.19 (+0.68%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

03/22/21
Fly Intel: Top five analyst downgrades
03/22/21 Piper Sandler
B&G Foods downgraded to Neutral from Overweight at Piper Sandler
03/03/21 RBC Capital
B&G Foods price target lowered to $29 from $32 at RBC Capital
01/19/21 Stephens
B&G Foods initiated with an Equal Weight at Stephens
BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

Earnings
Livent raises FY21 revenue view to $370M-$390M from $335M-$365M » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
LTHM

Livent

$20.38 /

+1.19 (+6.20%)

Consensus for FY21…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LTHM Livent
$20.38 /

+1.19 (+6.20%)

04/19/21
Fly Intel: Top five analyst upgrades
04/19/21 Evercore ISI
Evercore 'all in on lithium producers,' upgrades Livent to Outperform
04/19/21 Evercore ISI
Livent upgraded to Outperform from In Line at Evercore ISI
03/15/21 Credit Suisse
Livent assumed with a Neutral at Credit Suisse
LTHM Livent
$20.38 /

+1.19 (+6.20%)

  • 11
    Jun
LTHM Livent
$20.38 /

+1.19 (+6.20%)

Earnings
B&G Foods reports Q2 EPS 41c, consensus 49c » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
BGS

B&G Foods

$28.18 /

+0.19 (+0.68%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

03/22/21
Fly Intel: Top five analyst downgrades
03/22/21 Piper Sandler
B&G Foods downgraded to Neutral from Overweight at Piper Sandler
03/03/21 RBC Capital
B&G Foods price target lowered to $29 from $32 at RBC Capital
01/19/21 Stephens
B&G Foods initiated with an Equal Weight at Stephens
BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

Earnings
BigCommerce reports Q2 EPS (6c), consensus (11c) » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
BIGC

BigCommerce

$71.36 /

+2.16 (+3.12%)

Reports Q revenue $49M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

07/28/21 Needham
BigCommerce price target raised to $85 from $60 at Needham
07/23/21 Barclays
BigCommerce price target raised to $66 from $53 at Barclays
07/20/21 William Blair
New partnerships align with BigCommerce open SaaS strategy, says William Blair
07/07/21 Piper Sandler
Piper says integration with Amazon MFC strengthens BigCommerce bull case
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

  • 13
    Nov
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

Earnings
Magnite reports Q2 adjusted EPS 11c, consensus 12c » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
MGNI

Magnite

$30.70 /

+1.08 (+3.65%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGNI Magnite
$30.70 /

+1.08 (+3.65%)

MGNI Magnite
$30.70 /

+1.08 (+3.65%)

07/13/21 Stifel
Tremor International initiated with a Buy at Stifel
07/02/21 Craig-Hallum
Craig-Hallum says Magnite SpringServe deal more consequential than price implies
06/25/21 Macquarie
Google cookie delay removes near-term overhang on adtech, says Macquarie
06/11/21 Stephens
Magnite partnerships can help accelerate shift in spend to CTV, says Stephens
MGNI Magnite
$30.70 /

+1.08 (+3.65%)

MGNI Magnite
$30.70 /

+1.08 (+3.65%)

MGNI Magnite
$30.70 /

+1.08 (+3.65%)

Hot Stocks
Appian acquires Lana Labs, terms not disclosed » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
APPN

Appian

$111.98 /

+2.22 (+2.02%)

Appian announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APPN Appian
$111.98 /

+2.22 (+2.02%)

08/02/21 Truist
Appian price target lowered to $120 from $205 at Truist
05/25/21
Fly Intel: Top five analyst upgrades
05/25/21 Macquarie
Appian upgraded to Neutral after share correction at Macquarie
05/25/21 Macquarie
Appian upgraded to Neutral from Underperform at Macquarie
APPN Appian
$111.98 /

+2.22 (+2.02%)

Hot Stocks
Covetrus backs FY21 adjusted EBITDA view of $245M-$255M  16:58
08/05/21
08/05
16:58
08/05/21
16:58
CVET

Covetrus

$25.41 /

+0.475 (+1.90%)

 
ShowHide Related Items >><<
CVET Covetrus
$25.41 /

+0.475 (+1.90%)

CVET Covetrus
$25.41 /

+0.475 (+1.90%)

08/04/21 Credit Suisse
Covetrus assumed with a Neutral at Credit Suisse
07/12/21 Guggenheim
Covetrus upgraded to Buy from Neutral at Guggenheim
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Barclays
Covetrus initiated with an Overweight at Barclays
CVET Covetrus
$25.41 /

+0.475 (+1.90%)

Hot Stocks
Air Transport Services sees FY21 CapEx $550M » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
ATSG

Air Transport Services

$25.42 /

+0.53 (+2.13%)

The company said:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

06/21/21 Stifel
Air Transport Services resumed with a Buy at Stifel
10/12/20 Loop Capital
Air Transport Services upgraded to Buy from Hold at Loop Capital
ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

Earnings
Livent reports Q2 adjusted EPS 4c, consensus 2c » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
LTHM

Livent

$20.38 /

+1.19 (+6.20%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LTHM Livent
$20.38 /

+1.19 (+6.20%)

04/19/21
Fly Intel: Top five analyst upgrades
04/19/21 Evercore ISI
Evercore 'all in on lithium producers,' upgrades Livent to Outperform
04/19/21 Evercore ISI
Livent upgraded to Outperform from In Line at Evercore ISI
03/15/21 Credit Suisse
Livent assumed with a Neutral at Credit Suisse
LTHM Livent
$20.38 /

+1.19 (+6.20%)

  • 11
    Jun
LTHM Livent
$20.38 /

+1.19 (+6.20%)

Earnings
Covetrus reports Q2 adjusted EBITDA $66M vs. $63M last year » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
CVET

Covetrus

$25.41 /

+0.475 (+1.90%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVET Covetrus
$25.41 /

+0.475 (+1.90%)

CVET Covetrus
$25.41 /

+0.475 (+1.90%)

08/04/21 Credit Suisse
Covetrus assumed with a Neutral at Credit Suisse
07/12/21 Guggenheim
Covetrus upgraded to Buy from Neutral at Guggenheim
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Barclays
Covetrus initiated with an Overweight at Barclays
CVET Covetrus
$25.41 /

+0.475 (+1.90%)

Earnings
Air Transport Services reports Q2 adjusted EPS 35c, consensus 27c » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
ATSG

Air Transport Services

$25.42 /

+0.53 (+2.13%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

06/21/21 Stifel
Air Transport Services resumed with a Buy at Stifel
10/12/20 Loop Capital
Air Transport Services upgraded to Buy from Hold at Loop Capital
ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

Hot Stocks
MEI Pharma CFO Brian Drazba to retire at end of 2021 » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
MEIP

MEI Pharma

$2.66 /

+0.04 (+1.53%)

MEI Pharma announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEIP MEI Pharma
$2.66 /

+0.04 (+1.53%)

MEIP MEI Pharma
$2.66 /

+0.04 (+1.53%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
MEIP MEI Pharma
$2.66 /

+0.04 (+1.53%)

Earnings
Aligos Therapeutics reports Q2 EPS (79c), consensus (81c) » 16:57
08/05/21
08/05
16:57
08/05/21
16:57
ALGS

Aligos Therapeutics

$16.31 /

+0.85 (+5.50%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

07/08/21 Piper Sandler
Aligos should be bought into 'catalyst rich' second half, says Piper Sandler
06/21/21 Piper Sandler
Aligos reported 'robust data' in hepatitis B virus, says Piper Sandler
06/10/21 Piper Sandler
Aligos Therapeutics has data-rich month with robust lineup, says Piper Sandler
05/17/21 Piper Sandler
Aligos Therapeutics assumed with an Overweight at Piper Sandler
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

  • 01
    Jul
  • 16
    Oct
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

Earnings
Aligos Therapeutics reports Q2 EPS (79c), consensus (81c) » 16:57
08/05/21
08/05
16:57
08/05/21
16:57
ALGS

Aligos Therapeutics

$16.31 /

+0.85 (+5.50%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

07/08/21 Piper Sandler
Aligos should be bought into 'catalyst rich' second half, says Piper Sandler
06/21/21 Piper Sandler
Aligos reported 'robust data' in hepatitis B virus, says Piper Sandler
06/10/21 Piper Sandler
Aligos Therapeutics has data-rich month with robust lineup, says Piper Sandler
05/17/21 Piper Sandler
Aligos Therapeutics assumed with an Overweight at Piper Sandler
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

  • 01
    Jul
  • 16
    Oct
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

Earnings
Aligos Therapeutics reports Q2 EPS (79c), consensus (81c) » 16:57
08/05/21
08/05
16:57
08/05/21
16:57
ALGS

Aligos Therapeutics

$16.31 /

+0.85 (+5.50%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

07/08/21 Piper Sandler
Aligos should be bought into 'catalyst rich' second half, says Piper Sandler
06/21/21 Piper Sandler
Aligos reported 'robust data' in hepatitis B virus, says Piper Sandler
06/10/21 Piper Sandler
Aligos Therapeutics has data-rich month with robust lineup, says Piper Sandler
05/17/21 Piper Sandler
Aligos Therapeutics assumed with an Overweight at Piper Sandler
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

  • 01
    Jul
  • 16
    Oct
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

Earnings
Envestnet sees FY21 adjusted EPS $2.30-$2.35, consensus $2.14 » 16:57
08/05/21
08/05
16:57
08/05/21
16:57
ENV

Envestnet

$74.53 /

+0.23 (+0.31%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENV Envestnet
$74.53 /

+0.23 (+0.31%)

ENV Envestnet
$74.53 /

+0.23 (+0.31%)

07/22/21 Jefferies
Envestnet downgraded to Underperform from Buy at Jefferies
05/13/21 Truist
Envestnet price target lowered to $85 from $95 at Truist
04/06/21 Jefferies
Jefferies sees Envestnet slightly beating guidance in Q1
02/26/21 RBC Capital
Envestnet price target lowered to $79 from $96 at RBC Capital
ENV Envestnet
$74.53 /

+0.23 (+0.31%)

ENV Envestnet
$74.53 /

+0.23 (+0.31%)

Hot Stocks
Shake Shack sees FY21 domestic company-operated Shack openings 35-38  16:57
08/05/21
08/05
16:57
08/05/21
16:57
SHAK

Shake Shack

$92.68 /

+0.44 (+0.48%)

 
ShowHide Related Items >><<
SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

07/01/21 OTR Global
Shake Shack recovery trends accelerating, says OTR Global
06/07/21 Piper Sandler
Shake Shack shares remain undervalued, says Piper Sandler
05/25/21
Fly Intel: Top five analyst upgrades
05/25/21 Wedbush
Shake Shack upgraded to Outperform from Neutral at Wedbush
SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

Earnings
Aligos Therapeutics reports Q2 EPS (79c), consensus (81c) » 16:57
08/05/21
08/05
16:57
08/05/21
16:57
ALGS

Aligos Therapeutics

$16.31 /

+0.85 (+5.50%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

07/08/21 Piper Sandler
Aligos should be bought into 'catalyst rich' second half, says Piper Sandler
06/21/21 Piper Sandler
Aligos reported 'robust data' in hepatitis B virus, says Piper Sandler
06/10/21 Piper Sandler
Aligos Therapeutics has data-rich month with robust lineup, says Piper Sandler
05/17/21 Piper Sandler
Aligos Therapeutics assumed with an Overweight at Piper Sandler
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

  • 01
    Jul
  • 16
    Oct
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

Earnings
Certara reports Q2 adjusted EPS 3c, consensus 5c » 16:56
08/05/21
08/05
16:56
08/05/21
16:56
CERT

Certara

$27.99 /

+0.0398 (+0.14%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CERT Certara
$27.99 /

+0.0398 (+0.14%)

CERT Certara
$27.99 /

+0.0398 (+0.14%)

08/04/21 Credit Suisse
Certara assumed with a Neutral at Credit Suisse
07/23/21 Baird
Certara initiated with an Outperform at Baird
05/07/21 Barclays
Certara price target lowered to $35 from $40 at Barclays
03/02/21 Barclays
Certara initiated with an Overweight at Barclays
CERT Certara
$27.99 /

+0.0398 (+0.14%)

  • 25
    Mar
  • 11
    Dec
CERT Certara
$27.99 /

+0.0398 (+0.14%)

Earnings
Envestnet sees Q3 adjusted EPS 58c, consensus 49c » 16:56
08/05/21
08/05
16:56
08/05/21
16:56
ENV

Envestnet

$74.53 /

+0.23 (+0.31%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENV Envestnet
$74.53 /

+0.23 (+0.31%)

ENV Envestnet
$74.53 /

+0.23 (+0.31%)

07/22/21 Jefferies
Envestnet downgraded to Underperform from Buy at Jefferies
05/13/21 Truist
Envestnet price target lowered to $85 from $95 at Truist
04/06/21 Jefferies
Jefferies sees Envestnet slightly beating guidance in Q1
02/26/21 RBC Capital
Envestnet price target lowered to $79 from $96 at RBC Capital
ENV Envestnet
$74.53 /

+0.23 (+0.31%)

ENV Envestnet
$74.53 /

+0.23 (+0.31%)

Earnings
Outfront Media reports Q2 EPS (5c), consensus (11c) » 16:56
08/05/21
08/05
16:56
08/05/21
16:56
OUT

Outfront Media

$23.99 /

+0.96 (+4.17%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OUT Outfront Media
$23.99 /

+0.96 (+4.17%)

06/09/21 JPMorgan
Outfront valuation discount to Lamar should narrow, says JPMorgan
05/19/21 Citi
Outfront Media price target raised to $27 from $25 at Citi
05/06/21 Barrington
Outfront Media price target raised to $28 from $24 at Barrington
03/30/21 Morgan Stanley
Outfront Media price target raised to $24 from $22 at Morgan Stanley
OUT Outfront Media
$23.99 /

+0.96 (+4.17%)

  • 23
    Feb
Earnings
Shake Shack sees Q3 revenue $194M-$200M, consensus $198M » 16:56
08/05/21
08/05
16:56
08/05/21
16:56
SHAK

Shake Shack

$92.68 /

+0.44 (+0.48%)

Sees Q3 same-shack sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

07/01/21 OTR Global
Shake Shack recovery trends accelerating, says OTR Global
06/07/21 Piper Sandler
Shake Shack shares remain undervalued, says Piper Sandler
05/25/21
Fly Intel: Top five analyst upgrades
05/25/21 Wedbush
Shake Shack upgraded to Outperform from Neutral at Wedbush
SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

Earnings
nLight sees Q3 revenue $68M-$74M, consensus $69.9M » 16:56
08/05/21
08/05
16:56
08/05/21
16:56
LASR

nLight

$31.83 /

+0.51 (+1.63%)

Sees Q3 gross margin to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LASR nLight
$31.83 /

+0.51 (+1.63%)

02/18/21 DA Davidson
nLight price target raised to $48 from $30 at DA Davidson
02/18/21 Craig-Hallum
nLight price target raised to $48 from $32 at Craig-Hallum
02/18/21 Canaccord
nLight price target raised to $53 from $27 at Canaccord
01/21/21 Berenberg
nLight assumed with a Hold at Berenberg
LASR nLight
$31.83 /

+0.51 (+1.63%)

  • 04
    Mar
LASR nLight
$31.83 /

+0.51 (+1.63%)

LASR nLight
$31.83 /

+0.51 (+1.63%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.